Vardenafil

Vardenafil (CAS 224785-90-4), also marketed under the brand names Levitra and Vivanza, is a pharmaceutical active ingredient used in the treatment of erectile dysfunction. It belongs to the class of PDE5 inhibitors and is a regulated API sourced by pharmaceutical manufacturers and licensed compounding facilities for various medical applications.

Vardenafil is used as the primary active ingredient in finished oral dosage forms, including film-coated tablets and orally disintegrating tablet formats for global distribution. Licensed pharmaceutical manufacturers incorporate it into branded and generic prescription products subject to regulatory approval in their respective markets and jurisdictions.

Compounding pharmacies operating under appropriate licensing may source it as a bulk API for patient-specific formulations that meet strict USP or EP standards. Research organizations and analytical laboratories also procure it as a reference standard or for pharmacological study purposes to ensure high-quality testing and development.

Vardenafil is available as a white to off-white crystalline powder in bulk API form, typically supplied in quantities ranging from research-scale grams to commercial kilogram lots. It is produced to pharmaceutical-grade specifications, with documentation including CoA, HPLC purity data, and regulatory starting material or DMF support depending on supplier qualification.